You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Sclerosis Associated Retrovirus (MSRV)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MSRV-Env Burden in Normal Population

Completed
  • Multiple Sclerosis
  • No study treatments administered
  • Annemasse, France
    Etablissement Français du Sang Rhône Alpes - 1 route de Taninges
Oct 19, 2020

Multiple Sclerosis Trial in Ankara (Assessment)

Completed
  • Multiple Sclerosis
  • Assessment
  • Ankara, Turkey
    Gazi University
Aug 4, 2022

MSRV-Env Burden in Patients With Multiple Sclerosis Disease

Completed
  • Multiple Sclerosis (MS)
  • +4 more
  • No study treatments administered - blood draws only
  • Bron cedex, France
  • +3 more
Oct 19, 2020

Multiple Sclerosis Trial in Majadahonda, Madrid (Botulinum toxin type A infiltrations)

Completed
  • Multiple Sclerosis
  • Botulinum toxin type A infiltrations
  • Majadahonda, Madrid, Spain
  • +1 more
Aug 8, 2022

Multiple Sclerosis Trial in Basel, Geneva (GNbAC1, GNbAC1 )

Completed
  • Multiple Sclerosis
  • GNbAC1
  • GNbAC1 placebo
  • Basel, Switzerland
  • +1 more
Feb 5, 2021

Reading Problems Associated With Central Nervous System

Completed
  • Injury Brain
  • +4 more
  • eye tracking
  • Valladolid, Spain
    IOBA - Universidad de Valladolid
Feb 1, 2023

MS-ResearchBiomarkerS

Recruiting
  • Multiple Sclerosis
  • +10 more
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jan 26, 2022

    Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (GNbAC1, Placebo)

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • Sofia, Bulgaria
    • +11 more
    Oct 19, 2020

    Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (GNbAC1 Monoclonal Antibody)

    Terminated
    • Multiple Sclerosis, Relapsing-Remitting
    • GNbAC1 Monoclonal Antibody
    • Sofia, Bulgaria
    • +11 more
    Oct 19, 2020

    Suboptimally Controlled Participants Previously Taking Oral or

    Recruiting
    • Multiple Sclerosis
    • Cladribine Tablets
    • Cullman, Alabama
    • +66 more
    Nov 29, 2022

    Clinical Isolation Syndrome of Spinal Cord and Multiple

    Recruiting
    • Clinical Isolation Syndrome of Spinal Cord
    • Multiple Sclerosis
      • Beijin, China
        Peking University Third Hospital
      Jun 27, 2021

      Diabetes Type 1 Trial in Australia (GNbAC1, Placebo)

      Completed
      • Diabetes Mellitus Type 1
      • Macquarie University, New South Wales, Australia
      • +12 more
      Oct 19, 2020

      Associated Burden of Related Conditions in Alopecia Areata

      Completed
      • Alopecia Areata
      • +35 more
      • Exposure of interest (studies 2 & 3).
      • London, United Kingdom
        Momentum Data Ltd
      Dec 13, 2022

      Pharmacogenomics of Drug Safety in Multiple Sclerosis

      Recruiting
      • Multiple Sclerosis
        • Vancouver, British Columbia, Canada
        • +4 more
        May 13, 2021

        Healthy Volunteers Trial in Berlin (GNbAC1)

        Completed
        • Healthy Volunteers
        • Berlin, Germany
          PAREXEL Early Phase Clinical Unit
        Oct 19, 2020

        Multiple Sclerosis Trial (GNbAC1, GNbAC1 )

        Completed
        • Multiple Sclerosis
        • GNbAC1
        • GNbAC1 placebo
        • (no location specified)
        Oct 19, 2020

        Amyotrophic Lateral Sclerosis Trial in Worldwide (BIIB078, Placebo)

        Completed
        • Amyotrophic Lateral Sclerosis
        • La Jolla, California
        • +20 more
        Jan 13, 2022

        Multiple Sclerosis, Relapsing-Remitting Trial in Norway (dimethyl fumarate, injectable MS DMT)

        Completed
        • Multiple Sclerosis, Relapsing-Remitting
        • dimethyl fumarate
        • injectable MS DMT
        • Drammen, Norway
        • +6 more
        Sep 3, 2021

        Acute Optic Neuritis Network:International Study That

        Recruiting
        • Demyelinating Diseases
        • +4 more
        • non-interventional study
        • Aurora, Colorado
        • +25 more
        Oct 31, 2022

        Mitochondrial Dysfunction in Primary Progressive Multiple

        Recruiting
        • Multiple Sclerosis
          • Milan, MI, Italy
          • +1 more
          Aug 29, 2023

          Novel Peri Infusion Regimen on Infusion Associated Reactions

          Active, not recruiting
          • Frequency of Infusion Reactions in Novel Versus Standard Protocol in Multiple Sclerosis
          • Alemtuzumab Injection
          • Halifax, Nova Scotia, Canada
            Maritime Neurology
          Nov 11, 2020

          Optic Neuritis, Transverse Myelitis, Acute Disseminated Encephalomyelitis Trial in Switzerland

          Recruiting
          • Optic Neuritis
          • +16 more
            • Aarau, Aargau, Switzerland
            • +11 more
            Aug 18, 2021

            Comorbidities in Alopecia Areata in Czech Republic

            Active, not recruiting
            • Alopecia Areata
            • +26 more
            • Exposure of interest
            • Prague, Czechia
              Teaching Hospital of Royal Vineguards
            Oct 30, 2021

            Sleep Disorders and Quality of Life in Multiple Sclerosis

            Not yet recruiting
            • Sleep Disorder
              • (no location specified)
              Aug 24, 2023

              Orofacial Pain in Multiple Sclerosis

              Recruiting
              • Multiple Sclerosis
              • Diagnosis of pain
              • Varaždin, Croatia
                Varazdin General Hospital
              Sep 5, 2023